Certified by Founder Lodge
Metsera
United States - New York
START UP
1 Disclosed Funding Rounds $215,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and inje
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 14 ,2024 | Series B | $215,000,000 |
Viking Global Investors
Wellington Management
T. Rowe Price
Janus Henderson Investors
Newpath Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
